Spiro[indoline-tetrazolo[1,5-c]quinazoline] derivatives as candidate HDAC8 inhibitors: a molecular docking and ADMET analysis using the HDAC8–inhibitor complex (PDB 2V5X)
This study identifies novel spiro[indoline-tetrazolo[1,5-c]quinazoline] derivatives as promising non-hydroxamate HDAC8 inhibitors through molecular docking and ADMET analysis, demonstrating superior binding scores and favorable cytotoxicity profiles driven by specific pharmacophoric interactions that may offer improved selectivity and reduced toxicity compared to conventional inhibitors.